Kyeong-OK “KC” Chang, virologist with Kansas State University’s College of Veterinary Medicine, recently received a $3.7 million grant to further development of COVID-19 therapeutic treatment. (Photo courtesy K-State Marketing and Communications)
Kansas State University has received a five-year, $3.7 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to research a new treatment method for COVID-19.
According to a release from the university Friday, the principal investigator for the project is Virologist with the K-State College of Veterinary Medicine Kyeon-OK Chang. The project aims to complete development of a drug for pre-clinical studies, ultimately leading to a COVID-19 specific antiviral therapeutic treatment.
Chang says “there is currently an urgent and unmet need for the discovery and development of antiviral therapeutics for the treatment of SARS-CoV-2.
Chang’s group has been working on antiviral drug development against both human and animal coronaviruses for over a decade, with a focus on protease inhibitors.
The post $3.7 million NIH grant to support K-State researchers in development of COVID-19 treatment appeared first on News Radio KMAN.
